Switch to:
More From Other Websites
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Jun 30 2015
SAREPTA THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Amendments... Jun 30 2015
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Jun 30 2015
Sarepta Files Eteplirsen NDA, Secures $40M Debt Financing - Analyst Blog Jun 30 2015
BioMarin's NDA for DMD Drug Drisapersen Accepted by FDA - Analyst Blog Jun 30 2015
5 Biotech Stocks On Deck With The FDA Jun 30 2015
Top Analyst Upgrades and Downgrades: Apollo, Petrobras, Shopify, Fitbit, Sarepta, Lowe’s and More Jun 30 2015
​Sarepta CEO: Teamwork has been key to quick progress on Duchenne drug Jun 29 2015
Sarepta Takes Its Foot off the Gas Jun 29 2015
Orchid Island Capital Inc (ORC), Sarepta Therapeutics Inc (SRPT) & First Bancorp (FBP) Plunging:... Jun 29 2015
Sell The News In Sarepta Therapeutics Jun 29 2015
BioMarin, Sarepta Muscular Dystrophy Drugs Progress Jun 29 2015
SAREPTA THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation... Jun 29 2015
Sarepta Therapeutics Secures $40 Million in Debt Financing Jun 29 2015
Sarepta Therapeutics Completes NDA Submission to FDA for Eteplirsen for the Treatment of Duchenne... Jun 29 2015
Sarepta Submits DMD Drug for FDA Approval Review Jun 29 2015
Sarepta Therapeutics Secures $40 Million in Debt Financing Jun 29 2015
Sarepta Therapeutics Completes NDA Submission to FDA for Eteplirsen for the Treatment of Duchenne... Jun 29 2015
7:00 am Sarepta Therapeutics completes NDA Submission to FDA for Eteplirsen Jun 29 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK